Share on StockTwits

Healthequity’s (NYSE:HQY) quiet period is set to end on Tuesday, September 9th. Healthequity had issued 9,100,000 shares in its IPO on July 31st, StockRatingsNetwork.com reports. The total size of the offering was $127,400,000 based on an initial share price of $14.00. During Healthequity’s quiet period, underwriters and any insiders that worked on the IPO are restricted from issuing any research reports or earnings estimates for the company because of regulations issued by the Securities and Exchange Commission. Following the expiration of the company’s quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company.

A number of analysts have recently weighed in on HQY shares. Analysts at Robert W. Baird initiated coverage on shares of Healthequity in a research note on Tuesday, August 26th. They set a “neutral” rating and a $22.00 price target on the stock. They noted that the move was a valuation call. Separately, analysts at JPMorgan Chase & Co. initiated coverage on shares of Healthequity in a research note on Monday, August 25th. They set an “overweight” rating and a $25.00 price target on the stock. Finally, analysts at Wells Fargo & Co. initiated coverage on shares of Healthequity in a research note on Monday, August 25th. They set an “outperform” rating on the stock. One equities research analyst has rated the stock with a hold rating and four have given a buy rating to the company. Healthequity has an average rating of “Buy” and an average price target of $24.00.

Shares of Healthequity (NYSE:HQY) traded up 0.32% on Thursday, hitting $18.95. 13,797 shares of the company’s stock traded hands. Healthequity has a 52-week low of $16.11 and a 52-week high of $21.48. The stock has a 50-day moving average of $18.97 and a 200-day moving average of $18.97. The company has a market cap of $939.8 million and a P/E ratio of 128.50.

HealthEquity, Inc is technology-enabled services platforms that enables consumers to make healthcare saving and spending decisions.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.